{"name":"VINCI CAPITAL","permalink":"vinci-capital","crunchbase_url":"http://www.crunchbase.com/financial-organization/vinci-capital","homepage_url":"http://www.vincicapital.ch","blog_url":"","blog_feed_url":"","twitter_username":"","phone_number":"41-21-693-92-34 ","description":"Swiss PE firm","email_address":"info@vincicapital.ch","number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"tag_list":null,"alias_list":"","created_at":"Thu Jul 23 03:41:28 UTC 2009","updated_at":"Mon Jul 27 20:17:34 UTC 2009","overview":"<p>Vinci Capital is a leading Swiss private equity firm with over MCHF 200 under management. Since 1998 they have provided equity to over 30 Swiss technology and industrial companies to finance innovation, growth and succession-buyouts.</p>\n\n<p>Their investment team capitalizes on 40 years of cumulated experience in private equity and a solid operational background in growth, turn-around, consolidation, IPOs and M&amp;A situations.</p>","image":{"available_sizes":[[[150,30],"assets/images/resized/0005/3918/53918v1-max-150x150.jpg"],[[250,50],"assets/images/resized/0005/3918/53918v1-max-250x250.jpg"],[[284,57],"assets/images/resized/0005/3918/53918v1-max-450x450.jpg"]],"attribution":null},"offices":[{"description":"","address1":"PSE, BÃ¢timent C ","address2":"CH-1015 Lausanne ","zip_code":"","city":"","state_code":null,"country_code":"CHE","latitude":null,"longitude":null}],"relationships":[],"investments":[{"funding_round":{"round_code":"unattributed","source_url":"http://www.omnisens.ch/ditest/doc-news.php?id=239","source_description":"OMNISENS RAISES CHF 6,000,000 VENTURE FUNDING","raised_amount":5320000,"raised_currency_code":"USD","funded_year":2008,"funded_month":9,"funded_day":10,"company":{"name":"Omnisens","permalink":"omnisens","image":{"available_sizes":[[[150,53],"assets/images/resized/0005/3916/53916v1-max-150x150.jpg"],[[187,67],"assets/images/resized/0005/3916/53916v1-max-250x250.jpg"],[[187,67],"assets/images/resized/0005/3916/53916v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://onbiovc.com/evolva-sa-series-b-275m/","source_description":"Evolva, SA: Series B $27.5M","raised_amount":27500000,"raised_currency_code":"USD","funded_year":2009,"funded_month":12,"funded_day":7,"company":{"name":"Evolva","permalink":"evolva","image":{"available_sizes":[[[74,93],"assets/images/resized/0006/4029/64029v1-max-150x150.jpg"],[[74,93],"assets/images/resized/0006/4029/64029v1-max-250x250.jpg"],[[74,93],"assets/images/resized/0006/4029/64029v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"https://www.fis.dowjones.com/article.aspx?ProductIDFromApplication=32&aid=DJFVW00020091215e5cf0005l&r=Rss&s=DJFVW","source_description":"Evolva Goes Public In Reverse Merger, Raises $43M  ","raised_amount":16000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":12,"funded_day":11,"company":{"name":"Evolva","permalink":"evolva","image":{"available_sizes":[[[74,93],"assets/images/resized/0006/4029/64029v1-max-150x150.jpg"],[[74,93],"assets/images/resized/0006/4029/64029v1-max-250x250.jpg"],[[74,93],"assets/images/resized/0006/4029/64029v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"","source_description":"Cap Funding Report","raised_amount":8880000,"raised_currency_code":"USD","funded_year":2006,"funded_month":11,"funded_day":10,"company":{"name":"Datamars","permalink":"datamars","image":{"available_sizes":[[[150,31],"assets/images/resized/0008/8728/88728v1-max-150x150.jpg"],[[250,52],"assets/images/resized/0008/8728/88728v1-max-250x250.jpg"],[[251,53],"assets/images/resized/0008/8728/88728v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"","source_description":"Cap Funding Report","raised_amount":7500000,"raised_currency_code":"USD","funded_year":2005,"funded_month":4,"funded_day":15,"company":{"name":"immatics biotechnologies","permalink":"immatics-biotechnologies","image":{"available_sizes":[[[127,62],"assets/images/resized/0007/9914/79914v1-max-150x150.jpg"],[[127,62],"assets/images/resized/0007/9914/79914v1-max-250x250.jpg"],[[127,62],"assets/images/resized/0007/9914/79914v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"","source_description":"Cap Funding Report","raised_amount":4550000,"raised_currency_code":"USD","funded_year":2010,"funded_month":2,"funded_day":2,"company":{"name":"SolvAxis","permalink":"solvaxis","image":{"available_sizes":[[[150,27],"assets/images/resized/0009/6699/96699v1-max-150x150.png"],[[250,46],"assets/images/resized/0009/6699/96699v1-max-250x250.png"],[[334,62],"assets/images/resized/0009/6699/96699v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.kuros.ch/cms/upload/kuros_news/Jan_2005.pdf","source_description":"KUROS BIOSURGERY AG EXERCISES OPTION FOR CHF 6.1M (â‚¬ 4M) INVESTMENT","raised_amount":4000000,"raised_currency_code":"EUR","funded_year":2005,"funded_month":1,"funded_day":1,"company":{"name":"Kuros Biosurgery","permalink":"kuros-biosurgery","image":{"available_sizes":[[[106,150],"assets/images/resized/0009/9881/99881v1-max-150x150.jpg"],[[117,165],"assets/images/resized/0009/9881/99881v1-max-250x250.jpg"],[[117,165],"assets/images/resized/0009/9881/99881v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.kuros.ch/cms/upload/kuros_news/Oct_2005.pdf","source_description":"KUROS BIOSURGERY AG RAISES CHF 5.6M (â‚¬ 3.6M) IN ADDITIONAL FUNDING","raised_amount":3600000,"raised_currency_code":"EUR","funded_year":2005,"funded_month":10,"funded_day":1,"company":{"name":"Kuros Biosurgery","permalink":"kuros-biosurgery","image":{"available_sizes":[[[106,150],"assets/images/resized/0009/9881/99881v1-max-150x150.jpg"],[[117,165],"assets/images/resized/0009/9881/99881v1-max-250x250.jpg"],[[117,165],"assets/images/resized/0009/9881/99881v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.fiercebiotech.com/story/startup-biotech-lands-20m-round-ph2-allergy-trial/2011-03-28?utm_medium=rss&utm_source=rss","source_description":"Startup biotech lands $20M A round for Ph2 allergy trial","raised_amount":20000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":3,"funded_day":28,"company":{"name":"Anergis","permalink":"anergis","image":{"available_sizes":[[[150,74],"assets/images/resized/0012/8188/128188v1-max-150x150.jpg"],[[250,124],"assets/images/resized/0012/8188/128188v1-max-250x250.jpg"],[[450,224],"assets/images/resized/0012/8188/128188v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://pevc.dowjones.com/article?an=DJFVW00020121109e8b9q54sy&from=alert&pid=32&ReturnUrl=http%3a%2f%2fpevc.dowjones.com%3a80%2farticle%3fan%3dDJFVW00020121109e8b9q54sy%26from%3dalert%26pid%3d32","source_description":"Sensimed Raises CHF17M Series C for Noninvasive Glaucoma Diagnostic","raised_amount":17900000,"raised_currency_code":"USD","funded_year":2012,"funded_month":11,"funded_day":9,"company":{"name":"SENSIMED","permalink":"sensimed","image":{"available_sizes":[[[150,30],"assets/images/resized/0021/9816/219816v1-max-150x150.jpg"],[[200,41],"assets/images/resized/0021/9816/219816v1-max-250x250.jpg"],[[200,41],"assets/images/resized/0021/9816/219816v1-max-450x450.jpg"]],"attribution":null}}}}],"milestones":[],"providerships":[],"funds":[],"video_embeds":[],"external_links":[]}